Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Towards a prevention model of health care

Subjects

Health-care budgets are largely spent on treating the complications of chronic diseases, many of which have preventable risk factors. Here, we discuss some of the key issues in the necessary move towards a 'prevention model' of health care.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Ross, J. S. et al. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 14, 320–368 (2009).

    Article  CAS  Google Scholar 

  2. Yazicki, Y. & Simsek, I. Treatment options for rheumatoid athritis beyond TNF-α inhibitors. Exp. Rev. Clin. Pharm. 3, 663–666 (2010).

    Article  Google Scholar 

  3. Breckenridge, A., Mello, M. & Psaty, B. M. New horizons in pharmaceutical regulation. Nature Rev. Drug Discov. 11, 501–502 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The views expressed are personal and do not necessarily reflect the views of any of the regulatory agencies.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Alasdair Breckenridge or Hans-Georg Eichler.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

FURTHER INFORMATION

US Food and Drug Administration (Alzheimer's Disease: Developing Drugs for the Treatment of Early Stage Disease)

US Food and Drug Administration (In Vitro Companion Diagnostic Devices)

European Medicines Agency (Reflection paper on co-development of pharmacogenomics biomarkers and assays in the context of drug development)

European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

Mini-Sentinel

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Breckenridge, A., Eichler, HG. Towards a prevention model of health care. Nat Rev Drug Discov 12, 563–564 (2013). https://doi.org/10.1038/nrd4077

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4077

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing